Growth Metrics

Emergent BioSolutions (EBS) Amortization - Goodwill (2022 - 2023)

Emergent BioSolutions has reported Amortization - Goodwill over the past 2 years, most recently at $218.2 million for Q3 2023.

  • For Q3 2023, Amortization - Goodwill changed N/A year-over-year to $218.2 million; the TTM value through Dec 2024 reached $224.9 million, changed N/A, while the annual FY2023 figure was $218.2 million, 3156.72% up from the prior year.
  • Amortization - Goodwill for Q3 2023 was $218.2 million at Emergent BioSolutions, up from $6.7 million in the prior quarter.
  • Over five years, Amortization - Goodwill peaked at $218.2 million in Q3 2023 and troughed at $6.7 million in Q4 2022.